Transcranial direct current stimulation at home may lead to significant reductions in depression symptoms
Up to a third of people diagnosed with depression do not respond to antidepressants or therapy.
Oct 31, 2024
0
22
Up to a third of people diagnosed with depression do not respond to antidepressants or therapy.
Oct 31, 2024
0
22
For patients with major depressive disorder (MDD), seizure duration of 60 to 69 seconds induced by electroconvulsive therapy (ECT) is associated with the highest remission rates compared with seizure duration of less than ...
Jul 29, 2024
0
25
A magnetic therapy for persistent depression is in such demand in the Twin Cities that Allina Health has doubled its capacity with the opening of a new mental health center in Fridley, Minnesota.
Jul 1, 2024
0
30
A new pill that slowly releases ketamine could treat people with severe depression without giving them the psychedelic side effects of the often-misused drug, early trial results suggested on Monday.
Jun 29, 2024
0
70
Patients with moderate to severe treatment-resistant depression (TRD) might have better symptom relief from ketamine infusions than from electroconvulsive therapy (ECT), but those with severe TRD could benefit more from ECT ...
Jun 26, 2024
0
52
Not all patients with depression respond to medication. Two recently published studies provide additional information on how an alternative treatment, transcranial magnetic stimulation (TMS), could be further enhanced. TMS ...
Jun 24, 2024
0
39
Genetic factors are a small but significant contributor to severe depression that does not respond to standard therapy, according to researchers at Vanderbilt University Medical Center and Massachusetts General Hospital.
May 15, 2024
0
68
Electroconvulsive therapy (ECT) is a safe and effective treatment for serious mental illness, according to a study presented at the annual congress of the European Psychiatric Association, held from April 6 to 9 in Budapest, ...
Apr 29, 2024
0
25
Researchers have found that electroconvulsive therapy (ECT), where an electric current is passed through the brain, can reduce the severity of mental illnesses. The findings were presented at EPA 2024.
Apr 9, 2024
1
26
A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health insurers have yet to publish ...
Mar 15, 2024
0
39